(CTAS) Cintas - Overview
Stock: Uniforms, Mats, First Aid, Fire Safety, Restroom Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.82% |
| Yield on Cost 5y | 2.59% |
| Yield CAGR 5y | -16.16% |
| Payout Consistency | 93.9% |
| Payout Ratio | 37.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.2% |
| Relative Tail Risk | -6.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.32 |
| Alpha | -15.42 |
| Character TTM | |
|---|---|
| Beta | 0.609 |
| Beta Downside | 0.560 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.88% |
| CAGR/Max DD | 1.06 |
Description: CTAS Cintas January 29, 2026
Cintas Corporation (NASDAQ:CTAS) provides corporate-identity uniforms and a suite of support services-including uniform rental, facility cleaning, first-aid supplies, and fire-protection solutions-to businesses across the United States, Canada, and Latin America. Its operations are organized into three segments: Uniform Rental & Facility Services, First Aid & Safety Services, and All Other, delivering both rental and direct-sale models through a nationwide distribution network and local service representatives.
According to the company’s most recent earnings release (Q2 2024), Cintas generated $4.5 billion in revenue, up 6 % year-over-year, with adjusted earnings per share of $3.28 and an operating margin of 16 %. Same-store sales in the Uniform Rental segment rose 5 % YoY, reflecting continued demand from a tight labor market that keeps corporate hiring activity robust.
Key drivers for the sector include sustained U.S. employment growth (average non-farm payroll increase of ~210 k per month in 2023-24), heightened workplace-safety regulations that boost demand for flame-resistant and first-aid products, and inflationary pressure on labor and material costs that makes outsourced uniform services more cost-effective for manufacturers and service firms.
For a deeper quantitative dive, you might explore ValueRay’s detailed valuation models to assess how these dynamics could impact CTAS’s forward-looking earnings potential.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.90b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA -2.23 > 1.0 |
| NWC/Revenue: 13.56% < 20% (prev -0.27%; Δ 13.83% < -1%) |
| CFO/TA 0.22 > 3% & CFO 2.20b > Net Income 1.90b |
| Net Debt (3.04b) to EBITDA (2.86b): 1.06 < 3 |
| Current Ratio: 1.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (406.4m) vs 12m ago -1.03% < -2% |
| Gross Margin: 50.25% > 18% (prev 0.49%; Δ 4976 % > 0.5%) |
| Asset Turnover: 110.7% > 50% (prev 106.1%; Δ 4.59% > 0%) |
| Interest Coverage Ratio: 18.14 > 6 (EBITDA TTM 2.86b / Interest Expense TTM 101.1m) |
Altman Z'' 9.02
| A: 0.14 (Total Current Assets 3.54b - Total Current Liabilities 2.08b) / Total Assets 10.13b |
| B: 1.23 (Retained Earnings 12.42b / Total Assets 10.13b) |
| C: 0.19 (EBIT TTM 1.83b / Avg Total Assets 9.75b) |
| D: 2.68 (Book Value of Equity 15.23b / Total Liabilities 5.68b) |
| Altman-Z'' Score: 9.02 = AAA |
Beneish M -3.17
| DSRI: 0.99 (Receivables 1.48b/1.38b, Revenue 10.79b/9.94b) |
| GMI: 0.97 (GM 50.25% / 48.79%) |
| AQI: 0.76 (AQ_t 0.46 / AQ_t-1 0.60) |
| SGI: 1.09 (Revenue 10.79b / 9.94b) |
| TATA: -0.03 (NI 1.90b - CFO 2.20b) / TA 10.13b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of CTAS shares?
Over the past week, the price has changed by -0.25%, over one month by +2.84%, over three months by +5.03% and over the past year by -4.91%.
Is CTAS a buy, sell or hold?
- StrongBuy: 5
- Buy: 3
- Hold: 8
- Sell: 1
- StrongSell: 3
What are the forecasts/targets for the CTAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 216.8 | 13.7% |
| Analysts Target Price | 216.8 | 13.7% |
| ValueRay Target Price | 221.9 | 16.3% |
CTAS Fundamental Data Overview January 29, 2026
P/E Forward = 39.8406
P/S = 7.1182
P/B = 17.4026
P/EG = 3.4944
Revenue TTM = 10.79b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 2.86b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 603.5m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.04b USD (from netDebt column, last quarter)
Enterprise Value = 79.88b USD (76.84b + Debt 3.24b - CCE 200.8m)
Interest Coverage Ratio = 18.14 (Ebit TTM 1.83b / Interest Expense TTM 101.1m)
EV/FCF = 44.86x (Enterprise Value 79.88b / FCF TTM 1.78b)
FCF Yield = 2.23% (FCF TTM 1.78b / Enterprise Value 79.88b)
FCF Margin = 16.50% (FCF TTM 1.78b / Revenue TTM 10.79b)
Net Margin = 17.58% (Net Income TTM 1.90b / Revenue TTM 10.79b)
Gross Margin = 50.25% ((Revenue TTM 10.79b - Cost of Revenue TTM 5.37b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 50.28%)
Tobins Q-Ratio = 7.88 (Enterprise Value 79.88b / Total Assets 10.13b)
Interest Expense / Debt = 0.87% (Interest Expense 28.1m / Debt 3.24b)
Taxrate = 21.19% (133.2m / 628.5m)
NOPAT = 1.44b (EBIT 1.83b * (1 - 21.19%))
Current Ratio = 1.71 (Total Current Assets 3.54b / Total Current Liabilities 2.08b)
Debt / Equity = 0.73 (Debt 3.24b / totalStockholderEquity, last quarter 4.46b)
Debt / EBITDA = 1.06 (Net Debt 3.04b / EBITDA 2.86b)
Debt / FCF = 1.71 (Net Debt 3.04b / FCF TTM 1.78b)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.47% (Net Income 1.90b / Total Assets 10.13b)
RoE = 41.07% (Net Income TTM 1.90b / Total Stockholder Equity 4.62b)
RoCE = 26.00% (EBIT 1.83b / Capital Employed (Equity 4.62b + L.T.Debt 2.43b))
RoIC = 20.07% (NOPAT 1.44b / Invested Capital 7.20b)
WACC = 7.86% (E(76.84b)/V(80.08b) * Re(8.16%) + D(3.24b)/V(80.08b) * Rd(0.87%) * (1-Tc(0.21)))
Discount Rate = 8.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.81%
[DCF Debug] Terminal Value 79.28% ; FCFF base≈1.81b ; Y1≈1.90b ; Y5≈2.20b
Fair Price DCF = 91.17 (EV 39.49b - Net Debt 3.04b = Equity 36.46b / Shares 399.9m; r=7.86% [WACC]; 5y FCF grow 5.10% → 2.90% )
EPS Correlation: -75.89 | EPS CAGR: -19.19% | SUE: 0.12 | # QB: 0
Revenue Correlation: 99.18 | Revenue CAGR: 9.97% | SUE: 2.49 | # QB: 2
EPS current Year (2026-05-31): EPS=4.88 | Chg30d=+0.002 | Revisions Net=+12 | Growth EPS=+10.8% | Growth Revenue=+8.3%
EPS next Year (2027-05-31): EPS=5.40 | Chg30d=+0.004 | Revisions Net=+10 | Growth EPS=+10.7% | Growth Revenue=+7.3%